Neuro-psychological expertise

Behavioral testing and imaging

Behavioral testing

Do you think that integrating neuropsychological tools into clinical trials is essential? Our platform relies on several neuropsychologists and a series of adapted standardized tests.


Evaluation of specific cognitive functions

altered by cancer and cancer treatments using adapted, standardized cognitive tests


Examination of the effect

of short- and longer-term treatments on cognition


Evaluation of cognitive impairment

perceived by patients and of the impact of this impairment on quality of life


Identification of the relationship between

perceived impairment and objective cognitive scores


Consideration of patient psychological status

(anxiety, depression, fatigue…) to specifically grasp the impact of cancer and cancer treatments on cognition

Study of the influence of cognitive reserve

and metacognition on the incidence of cognitive impairment

Cognitive rehabilitation

as treatment

“ We use a dozen internationally-recognized standardized tests that enable thorough cognitive evaluation. Long-term memory, vision, verbal skills, attention, executive functions….Our original approach focuses on metacognition tasks while controlling patient anxiety, depression and fatigue as well as the effect of treatments”


Do you also think essential to identify and understand the anatomical abnormalities and functional brain impairment caused by cancer and cancer treatments ? Neuro-imaging aims to complement the study of cognitive behavioural impairment : anatomical and functional brain imaging studies improve the understanding of behavioural impairment.

Study of functional brain impairment

using brain imaging protocols: fMRI, PET (Positron Emission Tomography), currently in development

Study of anatomical brain impairment

following cancer and cancer treatments (techniques: VBM and DTI)

Comparing anatomical and functional brain

impairment with the results of cognitive behavioural tests

“ Our approach is original: we aim to understand cognitive impairment related to cancer by combining neuro-imaging and neuropsychology methods. Since 2007, the CNO’s experts have been working together to improve the understanding of the mechanisms involved. We are also pioneers in this area : in cancer and cognition, the complementarity of our expertise is truly unique within the international scientific community”